• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Advent Technologies Reports Q1 2023 Results

    5/15/23 7:00:00 AM ET
    $ADN
    Industrial Machinery/Components
    Miscellaneous
    Get the next $ADN alert in real time by email
    • Entered into a joint development agreement with Hyundai following the conclusion of a successful technology assessment.
    • Collaboration with Siemens Energy for maritime fuel cell solution, integrating combined reformer/fuel cell modules into power supply systems for yachts.
    • Opening of the new Hood Park manufacturing facility in Boston, MA, for state-of-the-art development and scale-up production.
    • Agreement with BASF to establish end-to-end supply chain for hydrogen fuel cell systems in Europe.
    • Working actively with the Greek State for the timely signing of Advent's Green HiPo project, following official ratification from the European Commission for funding of up to €782.1 million under the Important Projects of Common European Interest ("IPCEI") Hy2Tech Program.

    Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent" or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology space, today announced consolidated financial results for the three months ended March 31, 2023. All amounts are in U.S. dollars unless otherwise noted and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP").

    Q1 2023 Financial Highlights

    (All comparisons are to Q1 2022, unless otherwise stated)

    • Revenue of $1.0 million and income from grants of $0.5 million, for a total of $1.5 million.
    • Operating expenses of $11.6 million, a year-over-year decrease of $1.0 million, as administrative cost reductions implemented throughout 2022 were partially offset by an increase in research and development expenses.
    • Net loss in Q1 of $(12.0) million or $(0.23) per share.
    • Unrestricted cash reserves were $19.5 million as of March 31, 2023, a decrease of $13.4 million from December 31, 2022, driven by R&D and administrative and selling expenses, as well as annual insurance renewals, a $2.2 million increase in inventory and $1.9 million of capex spending in the first quarter.

    "We have further consolidated our operations and continue to develop our state-of-the-art technology, which has resulted in marked progress with joint development agreements and technology assessments. The focus towards the mobility sector and stationary power sector has been endorsed by significant opportunity wins for Advent," said Dr. Vasilis Gregoriou, Chairman and CEO of Advent Technologies. "We shall remain focused on successfully developing innovative fuel cell systems and expanding our collaboration agreements with world-class partners."

    Business Updates

    Joint Development Agreement with Hyundai Motor Company ("Hyundai"): On March 22, 2023, Advent and Hyundai announced the conclusion of a successful technology assessment. The assessment evaluated Advent's proprietary MEA technology for supplying Hyundai's high-temperature fuel cell needs, and following its success, the two companies entered into a Joint Development Agreement ("JDA"). The JDA solidifies the interest of one of the world leaders in fuel cell technology to further develop the HT-PEM technology in collaboration with Advent. The first step of the JDA focuses on the MEA. Advent's goal is to provide its MEAs and its HT-PEM fuel cell development expertise to co-develop with automotive manufacturers the next generation of fuel cells for heavy-duty mobility. The HT-PEM fuel cell technology is highly differentiated compared with the current LT-PEM technology because it allows a vehicle to operate with efuels such as eMethanol, biofuels, and low-purity hydrogen. It allows higher impurity in the hydrogen fuel or air intake, each of which are very common and have repeatedly hampered LT-PEM deployments in real-world conditions. HT-PEM fuel cells have built-in resilience, as they do not rely on water for conductivity, therefore eliminating the problems of operating in extreme heat, cold, or humid conditions, and have a higher efficiency as a result of their high-temperature operation which allows for optimized cooling, a critical performance parameter for heavy-duty trucks and aircraft. Based on these advantages, Advent will pursue strategic joint development agreements to achieve its goal of supplying key MEA components and technology to the mobility market.

    Maritime Fuel Cell Solution for Superyachts: On February 9, 2023, Advent announced a new maritime collaboration with Siemens Energy, a globally renowned energy technology company, offering sustainable solutions across the entire energy value chain. Advent and Siemens Energy will work together to develop a 50kW–500kW maritime fuel cell solution for a range of superyachts, which will provide a sustainable and reliable source of auxiliary power and offer improved power density. This maritime fuel cell solution is initially expected to be used as a hybrid power source, enabling clean electricity generation instead of using conventional diesel engines and generators for procedures such as anchoring and maneuvering. As part of the agreement, Siemens Energy has placed an initial order for twenty of Advent's methanol-powered Serene fuel cell systems. Following the completion of this project, the two parties will explore the potential of developing similar solutions for a wider range of business applications beyond maritime, such as industrial power solutions.

    Hood Park R&D and Manufacturing Facility: On March 6, 2023, Advent announced that it opened its new R&D and manufacturing facility at Hood Park in Boston, Massachusetts. Less than one month later, on April 3, 2023, Massachusetts Governor Maura Healey, along with other elected officials, esteemed guests and business partners, attended the grand opening celebration. Hood Park will enable Advent to scale-up and deliver on the increasing global demand for electrochemical components in the clean energy sector by including state-of-the-art coating machines to support the seamless transition from prototypes to production runs for advanced membranes and electrodes; a complete analytical facility dedicated to quality control, performance analysis, and improving product lifetime; fuel cell and water electrolysis test stations for statistical process control and development of next-generation MEA materials, and a mechanical engineering lab for developing automated assembly processes for MEAs. One of the products to be manufactured at Hood Park is the Ion Pair™ Advent MEA which is currently being developed within the framework of L'Innovator, the Company's joint development program with the U.S. Department of Energy. Advent intends that its proprietary fuel cell products, such as Serene and Honey Badger 50™, will use the Ion Pair™ Advent MEAs beginning in 2024. The Company expects that the introduction of the Ion Pair™ Advent MEA will significantly reduce the cost of our Serene flagship product suite and thus expand the immediately addressable market. Furthermore, the expected system increase in power density and lifetime will highly differentiate Advent's fuel cells in the heavy-duty mobility industry.

    Agreement with BASF: On May 9, 2023, Advent and BASF Environmental Catalyst and Metal Solutions, a global leader in precious metals and catalysis, jointly announced a new agreement to join efforts in building a closed loop component supply chain for fuel cells and enter discussions to extend the partnership into the field of water electrolysis. For 20 years, BASF Environmental Catalyst and Metal Solutions has been a leader in membrane and MEA technology for HT-PEM fuel cells with a strong foundation in precious metal services and catalysis. HT-PEM fuel cells operate at 120 to 180°C, offer a broad operating window and tolerate impurities in the hydrogen fuel source. The fuel cells also enable simplified cooling and need no humidification. Advent offers competitive fuel cell systems for stationary and portable applications based on methanol and on-site reforming. In the future, HT-PEM fuel cells will also be available for heavy duty mobility and maritime power uses. The scope of the agreement includes BASF's role in scaling up MEA production at Advent's planned state-of-the-art manufacturing facility in Western Macedonia, Greece, while offering Advent its full portfolio of products and services to enable circularity in key materials. Both companies will cooperate on BASF's latest membrane development, Celtec®-Z, and the new Ion Pair™ MEA by Advent, aiming for improved performance, lifetime, and cost competitiveness.

    Green HiPo Project: On March 29, 2023, Advent announced that its Chairman and CEO, Dr. Vasilis Gregoriou, was elected as the Chair of the IPCEI Hy2Tech Facilitation Group. The election took place at the 1st General Assembly for Hy2Tech and Hy2Use, two of the European Union's IPCEIs, which aim to promote research, innovation, and the first industrial deployment of hydrogen technology infrastructure in Europe. The General Assembly was held on March 28, 2023, in Berlin, and was attended by executives from companies with projects ratified by the EU under the IPCEI framework, as well as government and EU officials. Advent's Green HiPo project received a notification in June 2022 for up to €782.1 million in funding from the Greek State, the highest amount of funding received for a project under IPCEI Hy2Tech. The European Union officially ratified the project in July 2022. Green HiPo will be based in the Western Macedonia region of Greece, where a state-of-the-art facility will be established for the R&D and production of innovative fuel cells and electrolyzer systems. Advent has been actively working with the Greek State for the timely signing of the contract.

    Dr. Gregoriou concluded, "Advent continues to make significant progress, and with the endorsement of our technology platform and products, we now have a commercial portfolio that will advance throughout 2023 and beyond. We will continue to consolidate our business with a view to maximizing efficiency and effectiveness throughout our global operations, and to focus on core markets and significant projects. The opening of our R&D and manufacturing facility at Hood Park provides an anchor for our operations in North America. The Greek State is progressing with the process for initiating the Green HiPo project, and we will provide an update at the appropriate time. I remain confident in the potential of Advent and our technology, and I am very optimistic that we will continue to increase market share as economies embrace clean energy and decarbonization."

    Conference Call

    The Company will host a conference call on Monday, May 15, 2023, at 9:00 AM ET to discuss its results.

    To access the call please dial (888) 660-6182 from the United States, or (929) 203-0891 from outside the U.S. The conference call I.D. number is 3273042. Participants should dial in 5 to 10 minutes before the scheduled time.

    A replay of the call can also be accessed via phone through May 29, 2023, by dialing (800) 770-2030 from the U.S., or (647) 362-9199 from outside the U.S. The conference I.D. number is 3273042.

    About Advent Technologies Holdings, Inc.

    Advent Technologies Holdings, Inc. is a U.S. corporation that develops, manufactures, and assembles complete fuel cell systems as well as supplying customers with critical components for fuel cells in the renewable energy sector. Advent is headquartered in Boston, Massachusetts, with offices in California, Greece, Denmark, Germany, and the Philippines. With more than 150 patents issued, pending, and/or licensed for fuel cell technology, Advent holds the IP for next-generation HT-PEM that enables various fuels to function at high temperatures and under extreme conditions, suitable for the automotive, aviation, defense, oil and gas, marine, and power generation sectors. For more information, please visit www.advent.energy.

    Cautionary Note Regarding Forward-Looking Statements

    This press release includes forward-looking statements. These forward-looking statements generally can be identified by the use of words such as "anticipate," "expect," "plan," "could," "may," "will," "believe," "estimate," "forecast," "goal," "project," and other words of similar meaning. Each forward-looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others, the Company's ability to maintain the listing of the Company's common stock on Nasdaq; future financial performance; public securities' potential liquidity and trading; impact from the outcome of any known and unknown litigation; ability to forecast and maintain an adequate rate of revenue growth and appropriately plan its expenses; expectations regarding future expenditures; future mix of revenue and effect on gross margins; attraction and retention of qualified directors, officers, employees, and key personnel; ability to compete effectively in a competitive industry; ability to protect and enhance our corporate reputation and brand; expectations concerning our relationships and actions with our technology partners and other third parties; impact from future regulatory, judicial and legislative changes to the industry; ability to locate and acquire complementary technologies or services and integrate those into the Company's business; future arrangements with, or investments in, other entities or associations; and intense competition and competitive pressure from other companies worldwide in the industries in which the Company will operate; and the risks identified under the heading "Risk Factors" in our Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2023, as well as the other information we file with the SEC. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. You are encouraged to read our filings with the SEC, available at www.sec.gov, for a discussion of these and other risks and uncertainties. The forward-looking statements in this press release speak only as of the date of this document, and we undertake no obligation to update or revise any of these statements. Our business is subject to substantial risks and uncertainties, including those referenced above. Investors, potential investors, and others should give careful consideration to these risks and uncertainties.

    Presentation of Non-GAAP Financial Measures

    In addition to the results provided in accordance with U.S. GAAP throughout this press release, the Company has provided non-GAAP financial measures - Adjusted Net Income / (Loss) and Adjusted EBITDA - which present results on a basis adjusted for certain items. The Company uses these non-GAAP financial measures for business planning purposes and in measuring its performance relative to that of its competitors. The Company believes that these non-GAAP financial measures are useful financial metrics to assess its operating performance from period-to-period by excluding certain items that the Company believes are not representative of its core business. These non-GAAP financial measures are not intended to replace, and should not be considered superior to, the presentation of the Company's financial results in accordance with GAAP. The use of the terms Adjusted Net Income / (Loss) and Adjusted EBITDA may differ from similar measures reported by other companies and may not be comparable to other similarly titled measures. These measures are reconciled from the respective measures under GAAP in the appendix below.

    ADVENT TECHNOLOGIES HOLDINGS, INC.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (Amounts in USD thousands, except share and per share amounts)

     

    As of

    ASSETS

    March 31, 2023

    (Unaudited)

     

    December 31,

    2022

    Current assets:

    Cash and cash equivalents

    $

    19,545

     

     

    $

    32,869

     

    Accounts receivable

    563

     

     

     

    979

     

    Contract assets

    294

     

     

     

    52

     

    Inventories

     

    14,858

     

     

     

    12,620

     

    Prepaid expenses and Other current assets

    3,739

     

     

     

    2,980

     

    Total current assets

    38,999

     

     

    49,500

     

    Non-current assets:

     

     

     

     

    Goodwill

     

    5,742

     

     

     

    5,742

     

    Intangibles, net

     

    5,843

     

     

     

    6,062

     

    Property and equipment, net

    20,162

     

     

     

    17,938

     

    Right-of-use assets

     

    4,024

     

     

     

    4,055

     

    Other non-current assets

     

    5,754

     

     

     

    5,971

     

    Available for sale financial asset

     

    326

     

     

     

    320

     

    Total non-current assets

    41,851

     

     

    40,088

     

    Total assets

    $

    80,850

     

     

    $

    89,588

     

    LIABILITIES AND STOCKHOLDERS' EQUITY

     

     

     

     

     

    Current liabilities:

     

     

     

     

    Trade and other payables

    $

    5,397

     

     

    $

    4,680

     

    Deferred income from grants, current

     

    833

     

     

     

    801

     

    Contract liabilities

    986

     

     

     

    1,019

     

    Other current liabilities

     

    5,079

     

     

     

    4,703

     

    Operating lease liabilities

     

    2,424

     

     

     

    2,280

     

    Income tax payable

    187

     

     

     

    183

     

    Total current liabilities

    14,906

     

     

    13,666

     

    Non-current liabilities:

     

     

     

     

    Warrant liability

     

    608

     

     

     

    998

     

    Long-term operating lease liabilities

     

    9,407

     

     

     

    9,802

     

    Defined benefit obligation

     

    80

     

     

     

    72

     

    Deferred income from grants, non-current

     

    35

     

     

     

    50

     

    Other long-term liabilities

    746

     

     

     

    852

     

    Total non-current liabilities

    10,876

     

     

    11,774

     

    Total liabilities

    25,782

     

     

    25,440

     

    Commitments and contingent liabilities

     

     

     

     

     

    Stockholders' equity

     

     

     

     

    Common stock ($0.0001 par value per share; Shares authorized: 110,000,000 at

    March 31, 2023 and December 31, 2022; Issued and outstanding: 52,261,643 and

    51,717,720 at March 31, 2023 and December 31, 2022, respectively)

     

    5

     

     

     

    5

     

    Preferred stock ($0.0001 par value per share; Shares authorized: 1,000,000 at

    March 31, 2023 and December 31, 2022; nil issued and outstanding at March 31,

    2023 and December 31, 2022)

    -

     

     

     

    -

     

    Additional paid-in capital

     

    177,081

     

     

     

    174,509

     

    Accumulated other comprehensive loss

    (2,268

    )

     

     

    (2,604

    )

    Accumulated deficit

     

    (119,750

    )

     

     

    (107,762

    )

    Total stockholders' equity

    55,068

     

     

    64,148

     

    Total liabilities and stockholders' equity

    $

    80,850

     

     

    $

    89,588

     

     

    ADVENT TECHNOLOGIES HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

     

    (Amounts in USD thousands, except share and per share amounts)

     

    Three months ended March 31,

    (Unaudited)

    2023

    2022

    Revenue, net

    $

    977

     

     

    $

    1,256

     

    Cost of revenues

    (1,484

    )

    (1,517

    )

    Gross loss

     

    (507

    )

     

     

    (261

    )

    Income from grants

    534

     

    508

     

    Research and development expenses

     

    (3,141

    )

     

     

    (2,149

    )

    Administrative and selling expenses

    (8,489

    )

    (10,498

    )

    Amortization of intangibles

     

    (221

    )

     

     

    (699

    )

    Operating loss

     

    (11,824

    )

     

    (13,099

    )

    Fair value change of warrant liability

     

    390

     

     

     

    8,376

     

    Finance income / (expenses), net

    110

     

    (10

    )

    Foreign exchange gains / (losses), net

     

    (41

    )

     

     

    (17

    )

    Other income / (expenses), net

    173

     

    (3

    )

    Loss before income tax

     

    (11,192

    )

     

     

    (4,753

    )

    Income taxes

    (796

    )

    657

     

    Net loss

    $

    (11,988

    )

     

    $

    (4,096

    )

    Net loss per share

    Basic loss per share

     

    (0.23

    )

     

     

    (0.08

    )

    Basic weighted average number of shares

    52,003,168

     

    51,253,591

     

    Diluted loss per share

     

    (0.23

    )

     

     

    (0.08

    )

    Diluted weighted average number of shares

    52,003,168

     

    51,253,591

     

    ADVENT TECHNOLOGIES HOLDINGS, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

     

    (Amounts in USD thousands)

     

    Three months ended March 31,

    (Unaudited)

    2023

    2022

    Net Cash used in Operating Activities

     

    $

    (11,448

    )

     

    $

    (19,311

    )

     

     

    Cash Flows from Investing Activities:

     

     

     

     

     

     

    Purchases of property and equipment

     

     

    (911

    )

     

     

    (950

    )

    Purchases of intangible assets

    -

     

    (13

    )

    Advances for the acquisition of property and equipment

     

     

    (976

    )

     

     

    (50

    )

    Receipt of government grants

     

     

    -

     

     

     

    3

     

    Net Cash used in Investing Activities

     

    $

    (1,887

    )

     

    $

    (1,010

    )

     

     

    Net decrease in cash, cash equivalents, restricted cash and restricted cash equivalents

     

    $

    (13,335

    )

     

    $

    (20,321

    )

    Effect of exchange rate changes on cash, cash equivalent, restricted cash and restricted cash

    equivalents

    11

     

    (161

    )

    Cash, cash equivalents, restricted cash and restricted cash equivalents at the beginning of the period

     

     

    33,619

     

     

     

    79,764

     

    Cash, cash equivalents, restricted cash and restricted cash equivalents at the end of the period

    $

    20,295

     

    $

    59,282

     

     

     

     

     

     

     

     

    Supplemental Cash Flow Information

     

     

    Cash activities

     

     

     

     

     

     

    Interest paid

     

    $

    -

     

     

    $

    6

     

    Supplemental Non-GAAP Measures and Reconciliations

    In addition to providing measures prepared in accordance with GAAP, we present certain supplemental non-GAAP measures. These measures are EBITDA, Adjusted EBITDA and Adjusted Net Income / (Loss), which we use to evaluate our operating performance, for business planning purposes and to measure our performance relative to that of our peers. These non-GAAP measures do not have any standardized meaning prescribed by GAAP and therefore may differ from similar measures presented by other companies and may not be comparable to other similarly titled measures. We believe these measures are useful in evaluating the operating performance of Advent's ongoing business. These measures should be considered in addition to, and not as a substitute for net income, operating expense and income, cash flows and other measures of financial performance and liquidity reported in accordance with GAAP. The calculation of these non-GAAP measures has been made on a consistent basis for all periods presented.

    EBITDA and Adjusted EBITDA

    These supplemental non-GAAP measures are provided to assist readers in determining our operating performance. We believe this measure is useful in assessing performance and highlighting trends on an overall basis. We also believe EBITDA and Adjusted EBITDA are frequently used by securities analysts and investors when comparing our results with those of other companies. EBITDA differs from the most comparable GAAP measure, net income / (loss), primarily because it does not include interest, income taxes, depreciation of property, plant and equipment, and amortization of intangible assets. Adjusted EBITDA adjusts EBITDA for items such as one-time transaction costs, asset impairment charges, and fair value changes in the warrant liability.

    The following tables show a reconciliation of net loss to EBITDA and Adjusted EBITDA for the three months ended March 31, 2023 and 2022.

    EBITDA and Adjusted EBITDA

     

    Three months ended March 31,

    (Unaudited)

    (in Millions of US dollars)

     

    2023

    2022

     

    $ change

    Net loss

     

    $

    (11.99

    )

     

    $

    (4.10

    )

    (7.89

    )

    Depreciation of property and equipment

     

    $

    0.40

     

    $

    0.42

     

    (0.02

    )

    Amortization of intangibles

     

    $

    0.22

     

     

    $

    0.70

     

    (0.48

    )

    Finance income / (expenses), net

     

    $

    (0.11

    )

    $

    0.01

     

    (0.12

    )

    Other income / (expenses), net

     

    $

    (0.17

    )

     

    $

    -

     

    (0.17

    )

    Foreign exchange differences, net

     

    $

    0.04

     

    $

    0.02

     

    0.02

     

    Income taxes

     

    $

    0.80

     

     

    $

    (0.66

    )

    1.46

     

    EBITDA

     

    $

    (10.81

    )

     

    $

    (3.61

    )

    (7.20

    )

    Net change in warrant liability

     

    $

    (0.39

    )

     

    $

    (8.38

    )

    7.99

     

    Adjusted EBITDA

     

    $

    (11.20

    )

     

    $

    (11.99

    )

    0.79

     

    Adjusted Net Loss

    This supplemental non-GAAP measure is provided to assist readers in determining our financial performance. We believe this measure is useful in assessing performance and highlighting trends on an overall basis. Adjusted Net Loss differs from the most comparable GAAP measure, net loss, primarily because it does not include one-time transaction costs, asset impairment charges and warrant liability changes. The following table shows a reconciliation of net loss to Adjusted Net Loss for the three months ended March 31, 2023 and 2022.

    Adjusted Net Loss

     

    Three months ended March 31,

    (Unaudited)

    (in Millions of US dollars)

     

    2023

    2022

    $ change

    Net loss

     

    $

    (11.99)

     

    $

    (4.10)

    (7.89)

    Net change in warrant liability

     

    $

    (0.39)

    $

    (8.38)

    7.99

    Adjusted Net Loss

     

    $

    (12.38)

     

    $

    (12.48)

    0.10

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20230515005356/en/

    Get the next $ADN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ADN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ADN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Advent Technologies Announces Bryan Holasek as Chief Strategy Officer

      LIVERMORE, Calif., May 07, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology sector, is pleased to announce that Bryan Holasek has joined the Company as the Chief Strategy Officer. Mr. Holasek has over 42 years of experience in advancing technology from concept to product development. He was introduced to HT-PEM Fuel Cells through Trenergi Corp. He has founded several tech companies, including Revolutionary Integrations Group (AI and Machine Learning) and 369 Power and Energy Group (alternative energy systems). Previously, Mr. Holasek was Vice President of Corporate Dev

      5/7/25 8:00:00 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Holdings Receives Nasdaq Notice on Late Filing of its Form 10-K

      LIVERMORE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:ADN). Advent Technologies Holdings, Inc. announced today that, as expected, it received a notice from Nasdaq on April 16, 2025, notifying the Company that it is not in compliance with the periodic filing requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because the Company's Annual Report on Form 10-K for the year ended December 31, 2024 ("Fiscal Year 2024 10-K") was not filed with the Securities and Exchange Commission (the "SEC") by the required due date of March 31, 2025. This Notice received from Nasdaq has no immediate effect on the listing or trading of the Company's shares. Nasdaq has pro

      4/16/25 8:00:25 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies receives Go-Ahead from Airbus for Phase Two of Joint Benchmarking Project

      LIVERMORE, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology space, is pleased to announce that it has received the go-ahead decision from Airbus, a leading aircraft manufacturer, to proceed with Phase Two of the parties' joint benchmarking project for an optimized Ion Pair™ Membrane Electrode Assembly ("MEA") for hydrogen fuel cells. Having demonstrated continued improvement in Ion Pair™ MEA performance in Phase One, the parties seek to further optimize performance in Phase Two. Advent has invested in people, materials, hardware, and 3rd party research centers, to contribute to

      3/26/25 8:00:00 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    SEC Filings

    See more
    • Advent Technologies Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

      4/16/25 8:20:02 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Holdings Inc. filed SEC Form 8-K: Other Events

      8-K - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

      4/15/25 3:35:46 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form NT 10-K filed by Advent Technologies Holdings Inc.

      NT 10-K - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Filer)

      3/31/25 3:55:41 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    Financials

    Live finance-specific insights

    See more
    • Advent Technologies Reports Q4 2023 Results

      Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent" or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology space, announced on Tuesday, August 13, 2024 its consolidated financial results for the three months and year ended December 31, 2023. All amounts are in U.S. dollars unless otherwise noted and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). Q4 2023 Financial Highlights (All comparisons are to Q4 2022, unless otherwise stated) Revenue of $1.5 million and income from grants of $0.8 million, totaling $2.3 million, which represents a decrease of (3.6)% year-over-year. Full year 2023 revenue of $

      8/20/24 7:00:00 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Announces Date for Fourth Quarter and Fiscal 2023 Earnings Call

      Company to Report Q4 2023 Results on August 20, 2024 Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology sectors, today announced that it will host a conference call on Tuesday, August 20, 2024 at 9:00 AM ET to discuss its fourth quarter and fiscal 2023 financial results. A press release containing these results will be issued before the call. To access the call please dial (800) 715-9871 from the United States, or +1 (646) 307-1963 from outside the U.S. The conference call I.D. number is 9909908. Participants should dial in 5 to 10 minutes before the scheduled time. Participants can also attend the call virtually by vi

      8/14/24 9:28:00 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Reports Q3 2023 Results

      Operational Highlights Signed a term sheet with Airbus to launch a Joint Project for the potential use of HT-PEM fuel cells in aviation. Signed new supply contract with the U.S. Department of Defense of $2.2 million for portable power systems. Received order from a prominent fuel cell integrator in the Asian market with initial value of $1.3 million. Unveiled Advent's range of Serene Power Systems at the 2023 Monaco Yacht Show. Continued discussions with the Greek State to finalize its procedures for state aid funding of Advent's Green HiPo project, following official ratification from the European Commission under the Important Projects of Common European Interest ("IPCEI")

      11/14/23 7:00:00 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Advent Technologies Holdings Inc. (Amendment)

      SC 13G/A - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

      2/12/24 4:09:47 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SC 13G/A filed by Advent Technologies Holdings Inc. (Amendment)

      SC 13G/A - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

      1/10/24 2:49:54 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SC 13G/A filed by Advent Technologies Holdings Inc. (Amendment)

      SC 13G/A - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Subject)

      10/3/23 9:43:40 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Advent Technologies downgraded by Goldman with a new price target

      Goldman downgraded Advent Technologies from Buy to Neutral and set a new price target of $20.00

      5/18/21 6:31:17 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Jefferies initiated coverage on Advent Technologies with a new price target

      Jefferies initiated coverage of Advent Technologies with a rating of Buy and set a new price target of $18.00

      3/19/21 8:01:58 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Credit Suisse reiterated coverage on Acadian Timber with a new price target

      Credit Suisse reiterated coverage of Acadian Timber with a rating of Underperform and set a new price target of $18.00 from $16.00 previously

      3/17/21 8:43:34 AM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Director Dhaliwal Avtar

      4 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Issuer)

      4/2/25 2:16:33 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form 3 filed by new insider Dhaliwal Avtar

      3 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Issuer)

      4/2/25 2:15:48 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form 3 filed by new insider Lukash Seth M

      3 - ADVENT TECHNOLOGIES HOLDINGS, INC. (0001744494) (Issuer)

      3/11/25 5:56:13 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous

    $ADN
    Leadership Updates

    Live Leadership Updates

    See more
    • Advent Technologies Announces Management and Board Changes

      LIVERMORE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Advent Technologies Holdings, Inc. (NASDAQ:ADN) ("Advent "or the "Company"), an innovation-driven leader in the fuel cell and hydrogen technology space, is pleased to announce changes to its board and C-suite by removing Chairman and Chief Executive Officer, Vasilis Gregoriou and Chief Strategy Officer, Chris Kaskavelis. Gary Herman, an experienced turnaround executive has been appointed as Interim CEO. Mr. Herman stated, "The changes were long overdue. Advent has tremendous untapped potential. Its technology is unsurpassed and offers a ubiquitous clean energy solution across multiple industries including aviation, heavy automotive,

      10/30/24 6:10:38 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Receives Nasdaq Notification Regarding Compliance with Listing Requirements and Appoints Three New Directors

      Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology sectors, today announced that it has received a letter from the Listing Qualifications Department of the Nasdaq Stock Market ("Nasdaq") confirming that the Company has rectified its previous deficiency related to the filing of its annual report on Form 10-K on August 13, 2024. The letter also informed Advent Technologies that it remains noncompliant with Nasdaq Listing Rule 5250(c)(1) due to the delayed filing of its Quarterly Reports on Form 10-Q for the periods ended March 31, 2024 (the "First Quarter 10-Q") and June 30, 2024 (the "Second Quarter 10-Q" and, together with t

      9/4/24 6:01:00 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous
    • Advent Technologies Announces Appointment of Naiem Hussain as Chief Financial Officer

      Advent Technologies Holdings, Inc. (NASDAQ:ADN), an innovation-driven leader in the fuel cell and hydrogen technology space, announced today the appointment of Naiem Hussain as its new Chief Financial Officer pending the completion of the company's hiring protocols. Formerly serving as Advent's Chief Investment Officer, Mr. Hussain brings extensive expertise in corporate finance, with a focus on IPOs, fundraisings, and mergers and acquisitions within the energy technology and fuel cell industries. Mr. Hussain is replacing Kevin Brackman, who resigned from his position on January 5, 2024. Mr. Hussain's professional journey commenced at ICI plc, where he played a pivotal role in investor re

      1/11/24 6:03:00 PM ET
      $ADN
      Industrial Machinery/Components
      Miscellaneous